Industry Brief: Unpacking the drivers of dermatology dealmaking
Understand why M&A within dermatology has soared, and what have been the key factors underpinning its rise.
A few key points:
- 2018 may well eclipse the prior high of deal value in dermatology in the US, soaring beyond $5.6 billion
- PE buyers in particular have been boosting dermatology consolidation
- Dermatology is well-suited as an investment opportunity, in part due to its multiple product lines and revenue sources
Click here to get the full brief.